Save
Email
Print
ShareJuly 15, 2010 — How a retrovirus, like HIV, reproduces and assembles new viruses is different than previously thought, according to Penn State College of Medicine researchers. Understanding the steps a virus takes for assembly could allow development of a way to prevent the spread of retroviral diseases.
The team studied a chicken virus called Rous sarcoma virus that causes cancer in chickens and is similar to HIV.
"The question is, how do retroviruses build new virus particles?" asked Leslie Parent, M.D., Ph.D., professor of infectious diseases, department of medicine. "There are no inhibitors of HIV assembly in clinical use. If we can determine how retroviruses are built, we can help stop the spread of infection through the creation of new drugs."
The start of the replication process is the production by the retrovirus of a protein called Gag. Prior to this study, it was thought the building process happened outside the nucleus in the cyctoplasm -- the material that fills the cell -- and then Gag protein was sent to the plasma membrane -- the outer boundary of the cell. The researchers discovered, however, that Rous sarcoma virus takes a detour through the cell nucleus before going to the cell membrane.
The Gag protein has a signal, which tells a receptor to take it into the nucleus. Once in the nucleus, Gag binds to the viral RNA. The viral RNA alters the structure of the protein, changing the way it folds. This new configuration triggers a different signal that allows the Gag to move out of the nucleus.
"There's a sequence of events that has to happen in a very specific order," Parent explained. "The Gag protein has to find its own RNA, build a virus particle around it, and then release it from the cell." Finding the viral RNA is the first committed step in the assembly process. By focusing on regulatory processes in assembly, researchers are looking for key events that, if disrupted, could stop the virus from spreading.
"We want to understand the smallest building blocks of the virus particle," Parent said. "If we interfere with the first step, the virus will never be released from the cell. Cells are complex, so we use the key elements in a test tube to figure out how Gag and the RNA interact."
This study built on a 2002 paper, which proposed a model for the Gag protein's entry into the nucleus. The researchers reported in the Proceedings of the National Academy of Sciences that Gag does travel in the nucleus. Further study will examine how the Gag complex travels from the nucleus to the plasma membrane.
Working with Parent were Nicole Gudleski, department of microbiology and immunology; John M. Flanagan, Ph.D., professor, and Marcia C. Bewley, associate professor, department of biochemistry and molecular biology; and Eileen P. Ryan, division of infectious diseases, department of medicine.
A Penn State Hershey Cancer Institute seed grant, the National Institutes of Health, and the Pennsylvania Tobacco Settlement Fund supported this study.
Other social bookmarking and sharing tools:
Story Source:
The above story is reprinted from materials provided by Penn State, via EurekAlert!, a service of AAAS.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
Journal Reference:
- N. Gudleski, J. M. Flanagan, E. P. Ryan, M. C. Bewley, L. J. Parent. Directionality of nucleocytoplasmic transport of the retroviral gag protein depends on sequential binding of karyopherins and viral RNA. Proceedings of the National Academy of Sciences, 2010; 107 (20): 9358 DOI: 10.1073/pnas.1000304107
Note: If no author is given, the source is cited instead.
more 
